ClinicalTrials.gg
Not yet recruitingNCT06871371Updated Mar 11, 2025

Low and Moderete Flow Anaesthesia on Haemodynamics

An interventional study of Sevoflurane (Volatile Anesthetic) and low- medium flow anesthetic machine in Hemodynamics Instability, Arrhythmias Cardiac and Cerebral Oxygenation, sponsored by Umraniye Education and Research Hospital. Not yet recruiting at 1 site in Turkey. Open to participants aged 17 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-03-11.

Sponsored by Umraniye Education and Research Hospital · Not applicable, Interventional, and Screening

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 7 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
17 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 23 studies in Arrhythmias, Cardiac with a site in Turkey — 3 open to participants now, 5 under way, none of them phase 3. Arrhythmias, Cardiac · Turkey.

Planned enrollment
4th of 12
76 · median 63
Started
2025
with 2 others
No phase
10 of 23
3 open now
Registered
16th of 23
by date

Among the 23 studies in Arrhythmias, Cardiac with a site in Turkey, this one is the 4th largest by planned enrollment of the 12 interventional ones that give a count, is one of 3 that started in 2025, is one of 10 with no phase, and was the 16th registered.

Arrhythmias, Cardiac

1,052 studies on the registry are indexed under Arrhythmias, Cardiac; 236 are open to participants now.

Browse Arrhythmias, Cardiac studies →

Open to participants now

3 of the 23 studies in Arrhythmias, Cardiac with a site in Turkey are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 167 Arrhythmias, Cardiac studies recruiting now, 119 (71%) set no upper age limit and 13 (8%) stop at 75 or younger; 31 take children under 18; 26 take healthy volunteers.

This study: 17 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Arrhythmias, Cardiac with a site in Turkey, or all of them as a file.
02

Study summary

The study topic investigates the potential advantages of low-flow anesthesia in terms of physiological protection and resource saving.

Read the detailed description

The study aims to compare the effects of low and normal flow sevoflurane anesthesia on the frontal QRS-T angle and cerebral oxygenation in laparoscopic cholecystectomy surgery. The primary objective was to evaluate the effects of low-flow anesthesia on hemodynamic stability and arrhythmia risk; the secondary objective was to compare the total sevoflurane consumption in both methods.

03

Conditions studied

  • Hemodynamics Instability
  • Arrhythmias Cardiac
  • Cerebral Oxygenation

Keywords

  • Low-Medium Flow Anesthesia, Hemodynamics, Oxygenation
04

Who can participate

Ages eligible
17 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • being ASA1-2 status
  • between the ages of 18-70
  • who are planned for laparoscopic cholecystectomy

Exclusion criteria

Exclusion Criteria:

  • Patients who refuse to give
  • Pregnant and breastfeeding patients
  • Morbidly obese patients ( over 40)
  • Patients with uncontrolled diabetes mellitus, with serious cardiovascular, pulmonary, renal, hepatic disease, obstructive sleep apnea, with electrolyte imbalance- Those with a history of alcohol or drug abuse, with perioperative hemodynamic instability
  • Patients using drugs known to prolong myocardial repolarization
  • inability to increase SPO2 above 95 despite necessary intervention
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
76 participants (estimated)

Study arms

  • Active comparator
    low flow anesthesia

    Maintenance of anaesthesia with low-flow anaesthesia

    Device: Sevoflurane (Volatile Anesthetic) · Device: low- medium flow anesthetic machine

  • Active comparator
    Medium Flow Anesthesia

    Maintenance of anaesthesia with medium-flow anaesthesia

    Device: Sevoflurane (Volatile Anesthetic) · Device: low- medium flow anesthetic machine

Interventions

  • DeviceSevoflurane (Volatile Anesthetic)

    Both groups will be given sevoflurane and one group will be given low current anesthesia and the other group will be given medium flow anesthesia.

  • Devicelow- medium flow anesthetic machine

    The study aims to compare the effects of low and normal flow sevoflurane anesthesia on the frontal QRS-T angle and cerebral oxygenation in laparoscopic cholecystectomy surgery.

06

What researchers measure

Primary outcomes

  1. the effects of low-flow anesthesia on hemodynamic stability

    The primary objective was to detect the adverse effects of low-flow anesthesia on hemodynamic stability and arrhythmia risk

    Time frame: in 2 months

Secondary outcomes

  1. the cerebral oxygenation

    The primary objective was to detect the adverse effects of low-flow anesthesia on cerebral oxygenation

    Time frame: in 2 months

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2025; primary completion for Apr 2025, 1 month later.

Of 172 non-industry interventional studies with no phase under Arrhythmias, Cardiac, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 43. This study's planned 1 month is below that.

Counting every sponsor, half of 243 studies reached it within 24 months; a quarter within 12 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 26, 2025
First posted
Mar 11, 2025
StartEst.
Mar 15, 2025
Primary completionEst.
Apr 15, 2025
CompletionEst.
Apr 15, 2025
Last update
Mar 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06871371
Lead sponsor
Umraniye Education and Research Hospital
Responsible party
Senay Goksu (specialist, Umraniye Education and Research Hospital) — Principal investigator
First posted
Mar 11, 2025
Start date
Mar 15, 2025 (estimated)
Primary completion
Apr 15, 2025 (estimated)
Completion
Apr 15, 2025 (estimated)
Last update
Mar 11, 2025

Study contacts

senay goksu, specialist doctor
Contact
senaytomruk@hotmail.com
+905337144852
SENAY GOKSU, MD
principal investigator · UMRANIYE E R HOSPITAL

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion